ポリメラーゼ連鎖反応技術市場：技術別（リアルタイムPCR、トラディショナルPCR、デジタルPCR）、製品別（試薬・消耗品、機器、ソフトウェア、サービス）、エンドユーザー別（診断センター・病院、バイオテック・製薬会社、学術・研究機関）。世界の市場機会分析および産業予測、2020-2030年

Polymerase Chain Reaction Technologies Market By Technology (Real-Time PCR, Traditional PCR, Digital PCR), By Product (Reagents & Consumables, Instruments, Software, Services), By End Users (Diagnostic Centers & Hospitals, Biotech & Pharma Companies, Academic & Research Institutions): Global Opportunity Analysis and Industry Forecast, 2020-2030

ポリメラーゼ連鎖反応技術の世界市場規模は2020年に166億6930万ドル、2030年には287億5510万ドルに達し、2021年から2030年までのCAGRは4.1%と予測されています。ポリメラーゼ連鎖反応（PCR）は、DNAの断片の単一... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$5,769 シングルユーザーライセンスライセンス・価格情報・注文方法はこちら	230	英語

サマリー

ポリメラーゼ連鎖反応技術の世界市場規模は2020年に166億6930万ドル、2030年には287億5510万ドルに達し、2021年から2030年までのCAGRは4.1%と予測されています。ポリメラーゼ連鎖反応（PCR）は、DNAの断片の単一またはほとんどないコピーをアップグレードする分子生物学における巨大な一貫した方法論である。同様に、特定のDNAのコピーを数千から数百万単位で作成し、エイズ、結核、ライム病、中耳炎などの病気を調査する際にも有用である。この開発には、変性、硬化、伸長の3つの大きな進歩が含まれている。臨床、研究、臨床診断、正統科学に適用可能である。核酸（RNAやDNA）を研究するための標準的な方法として、昔から研究室で利用されている。市場で入手可能なPCRの進歩は、ノンストップ定量（qPCR）、機械化PCR（dPCR）、コンピュータ化PCR、多重PCR、収集PCR、および標準PCRである。病気を認識するための臨床的考察における強力な例示的診断システムの必要性は、市場の進歩のためのプレミアムを後押ししています。
感染症や圧倒的な汚染の成長の進歩は、ポリメラーゼ連鎖反応技術市場を駆動します。例えば、癌は世界中で死亡の主な理由の一つである。国立がん研究所によると、多くの人々が癌の悪影響を経験します。一貫した汚染に遭遇する患者の量の上昇のアカウントで、病気の早期調査のためのPCRヘッドウェイのためのプレミアムの開発があります。現在では、様々な機関が、感染の回避の進展に伴い、早期治療に着手しています。このような感染症の早期発見のために、PCR法への関心が高まっています。したがって、これは市場の発展にプラスの影響を与えます。また、業界の主要部分によってPCRの進行は、ポリメラーゼ連鎖反応技術市場を駆動する強力な障害、脅迫開発、血液スクリーニング、および様々なアプリケーションの様々な種類の認識のための臨床サービスの専門家に開いて高度なソリューションを作ることによって、市場の発展を支援するものである。
しかし、PCR検査は、様々な汚染の検査に使用することができます。それにもかかわらず、指標となる検査にPCR進行を使用することに関連するコストは高いです。その結果、患者はそのような検査を選択しない。同様に、様々な国がこれらの検査に償還を与えていない。このような状況が続くと、遺伝性疾患、分子細胞遺伝学、癌検査などの主要な分子検査に対する償還が減少することになる。その結果、償還オプションのnonappearanceはさらにPCR開発のためのポリメラーゼ連鎖反応技術市場の成長を阻害する。
逆に、このような癌の成長と汚染などの感染症や病気の発生の上昇は、これらの疾患の早期認知に役立つ可能性があり、特徴的な技術の関心を拡大してきました。このため、これらの疾患の早期発見に役立つ研究開発活動への資金援助が拡大しています。さらに、重要な団体は、この分野での発展と需要を見込んで、PCRなどの分子診断法の進歩に資産を投入しています。様々な目的のためにPCRの使用を組み込んだR＆D実践のための後援の拡張は、これらの進歩の使用を拡張し、新しいポリメラーゼ連鎖反応技術の機会を提供することができる可能性があります。
ポリメラーゼ連鎖反応技術市場は、技術、製品、アプリケーション、エンドユーザー産業、地域に基づいてセグメント化されています。技術別では、市場はリアルタイムPCR、トラディショナルPCR、デジタルPCRに分けられます。製品別では、試薬・消耗品、機器、ソフトウェア、サービスに細分化されます。アプリケーション別では、臨床、研究、フォレンジックに分類される。エンドユーザー別では、診断センター・病院、バイオテック・製薬会社、学術・研究機関に区分されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、イタリア、スペイン、その他の欧州）、アジア太平洋（中国、日本、韓国、インド、その他のアジア太平洋）、LAMEA（中南米、中東、アフリカ）で分析されています。
ポリメラーゼ連鎖反応技術市場でプロファイルされている主要なプレーヤーは、Abcam plc.(Expedeon AG）、Agilent Technologies, Inc.、bioMerieux SA、Bio-Rad Laboratories, Inc.が含まれます。ホフマン・ラ・ロシュ社、フルイディグム社、LGC Limited、キアゲン社、タカラバイオ社、サーモフィッシャーサイエンティフィック社などがあります。市場の主要企業は、ポリメラーゼ連鎖反応技術市場において、顧客により良い製品とサービスを提供するために、主要な開発戦略として製品発売、パートナーシップ、契約を採用しています。

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY
4.1 Overview
4.1.1 Market size and forecast
4.2 Real-Time PCR
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Traditional PCR
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Digital PCR
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT
5.1 Overview
5.1.1 Market size and forecast
5.2 Reagents & Consumables
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Instruments
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Software
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Services
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS
6.1 Overview
6.1.1 Market size and forecast
6.2 Diagnostic Centers & Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Biotech & Pharma Companies
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Academic & Research Institutions
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 Europe
7.2.1 Key trends and opportunities
7.2.2 Europe Market size and forecast, by Technology
7.2.3 Europe Market size and forecast, by Product
7.2.4 Europe Market size and forecast, by End Users
7.2.5 Europe Market size and forecast, by country
7.2.5.1 Germany
7.2.5.1.1 Market size and forecast, by Technology
7.2.5.1.2 Market size and forecast, by Product
7.2.5.1.3 Market size and forecast, by End Users
7.2.5.2 United Kingdom
7.2.5.2.1 Market size and forecast, by Technology
7.2.5.2.2 Market size and forecast, by Product
7.2.5.2.3 Market size and forecast, by End Users
7.2.5.3 France
7.2.5.3.1 Market size and forecast, by Technology
7.2.5.3.2 Market size and forecast, by Product
7.2.5.3.3 Market size and forecast, by End Users
7.2.5.4 Italy
7.2.5.4.1 Market size and forecast, by Technology
7.2.5.4.2 Market size and forecast, by Product
7.2.5.4.3 Market size and forecast, by End Users
7.2.5.5 Rest of Europe
7.2.5.5.1 Market size and forecast, by Technology
7.2.5.5.2 Market size and forecast, by Product
7.2.5.5.3 Market size and forecast, by End Users
7.3 Asia-Pacific
7.3.1 Key trends and opportunities
7.3.2 Asia-Pacific Market size and forecast, by Technology
7.3.3 Asia-Pacific Market size and forecast, by Product
7.3.4 Asia-Pacific Market size and forecast, by End Users
7.3.5 Asia-Pacific Market size and forecast, by country
7.3.5.1 China
7.3.5.1.1 Market size and forecast, by Technology
7.3.5.1.2 Market size and forecast, by Product
7.3.5.1.3 Market size and forecast, by End Users
7.3.5.2 Japan
7.3.5.2.1 Market size and forecast, by Technology
7.3.5.2.2 Market size and forecast, by Product
7.3.5.2.3 Market size and forecast, by End Users
7.3.5.3 South Korea
7.3.5.3.1 Market size and forecast, by Technology
7.3.5.3.2 Market size and forecast, by Product
7.3.5.3.3 Market size and forecast, by End Users
7.3.5.4 India
7.3.5.4.1 Market size and forecast, by Technology
7.3.5.4.2 Market size and forecast, by Product
7.3.5.4.3 Market size and forecast, by End Users
7.3.5.5 Rest of Asia-Pacific
7.3.5.5.1 Market size and forecast, by Technology
7.3.5.5.2 Market size and forecast, by Product
7.3.5.5.3 Market size and forecast, by End Users
7.4 North America
7.4.1 Key trends and opportunities
7.4.2 North America Market size and forecast, by Technology
7.4.3 North America Market size and forecast, by Product
7.4.4 North America Market size and forecast, by End Users
7.4.5 North America Market size and forecast, by country
7.4.5.1 U.S.
7.4.5.1.1 Market size and forecast, by Technology
7.4.5.1.2 Market size and forecast, by Product
7.4.5.1.3 Market size and forecast, by End Users
7.4.5.2 Canada
7.4.5.2.1 Market size and forecast, by Technology
7.4.5.2.2 Market size and forecast, by Product
7.4.5.2.3 Market size and forecast, by End Users
7.4.5.3 Mexico
7.4.5.3.1 Market size and forecast, by Technology
7.4.5.3.2 Market size and forecast, by Product
7.4.5.3.3 Market size and forecast, by End Users
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Technology
7.5.3 LAMEA Market size and forecast, by Product
7.5.4 LAMEA Market size and forecast, by End Users
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Latin America
7.5.5.1.1 Market size and forecast, by Technology
7.5.5.1.2 Market size and forecast, by Product
7.5.5.1.3 Market size and forecast, by End Users
7.5.5.2 Middle East
7.5.5.2.1 Market size and forecast, by Technology
7.5.5.2.2 Market size and forecast, by Product
7.5.5.2.3 Market size and forecast, by End Users
7.5.5.3 Africa
7.5.5.3.1 Market size and forecast, by Technology
7.5.5.3.2 Market size and forecast, by Product
7.5.5.3.3 Market size and forecast, by End Users
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 AGILENT TECHNOLOGIES
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 INC
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 BIOMERIEUX S.A
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 BIO-RAD LABORATORIES
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 INC
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 F. HOFFMANN-LA ROCHE AG (ROCHE)
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 FLUIDIGM CORPORATION
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 LGC LIMITED
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 QIAGEN N.V
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 SYGNIS AG
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 TAKARA BIO INC
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 THERMO FISHER SCIENTIFIC INC
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 2. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR REAL-TIME PCR, BY REGION , 2020-2030,($MILLION)
TABLE 3. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REAL-TIME PCR BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR TRADITIONAL PCR, BY REGION , 2020-2030,($MILLION)
TABLE 5. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET TRADITIONAL PCR BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR DIGITAL PCR, BY REGION , 2020-2030,($MILLION)
TABLE 7. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET DIGITAL PCR BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 9. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR REAGENTS & CONSUMABLES, BY REGION , 2020-2030,($MILLION)
TABLE 10. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REAGENTS & CONSUMABLES BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR INSTRUMENTS, BY REGION , 2020-2030,($MILLION)
TABLE 12. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET INSTRUMENTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR SOFTWARE, BY REGION , 2020-2030,($MILLION)
TABLE 14. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET SOFTWARE BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR SERVICES, BY REGION , 2020-2030,($MILLION)
TABLE 16. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET SERVICES BY COUNTRY, 2020-2030,($MILLION)
TABLE 17. GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2020-2030,($MILLION)
TABLE 18. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR DIAGNOSTIC CENTERS & HOSPITALS, BY REGION , 2020-2030,($MILLION)
TABLE 19. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET DIAGNOSTIC CENTERS & HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
TABLE 20. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR BIOTECH & PHARMA COMPANIES, BY REGION , 2020-2030,($MILLION)
TABLE 21. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BIOTECH & PHARMA COMPANIES BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION , 2020-2030,($MILLION)
TABLE 23. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET ACADEMIC & RESEARCH INSTITUTIONS BY COUNTRY, 2020-2030,($MILLION)
TABLE 24. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 25. EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 26. EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 27. EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2020-2030,($MILLION)
TABLE 28. EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. GERMANY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 30. GERMANY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 31. GERMANY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 32. UNITED KINGDOM POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 33. UNITED KINGDOM POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 34. UNITED KINGDOM POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 35. FRANCE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 36. FRANCE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 37. FRANCE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 38. ITALY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 39. ITALY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 40. ITALY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 41. REST OF EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 42. REST OF EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 43. REST OF EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 44. ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 45. ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 46. ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2020-2030,($MILLION)
TABLE 47. ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 48. CHINA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 49. CHINA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 50. CHINA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 51. JAPAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 52. JAPAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 53. JAPAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 54. SOUTH KOREA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 55. SOUTH KOREA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 56. SOUTH KOREA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 57. INDIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 58. INDIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 59. INDIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 60. REST OF ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 61. REST OF ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 62. REST OF ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 63. NORTH AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 64. NORTH AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 65. NORTH AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2020-2030,($MILLION)
TABLE 66. NORTH AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 67. U.S. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 68. U.S. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 69. U.S. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 70. CANADA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 71. CANADA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 72. CANADA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 73. MEXICO POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 74. MEXICO POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 75. MEXICO POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 76. LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 77. LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 78. LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2020-2030,($MILLION)
TABLE 79. LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 80. LATIN AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 81. LATIN AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 82. LATIN AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 83. MIDDLE EAST POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 84. MIDDLE EAST POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 85. MIDDLE EAST POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 86. AFRICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 87. AFRICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 88. AFRICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
TABLE 89.AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 90.AGILENT TECHNOLOGIES: OPERATING SEGMENTS
TABLE 91.AGILENT TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 92.AGILENT TECHNOLOGIES: NET SALES,
TABLE 93.AGILENT TECHNOLOGIES: KEY STRATERGIES
TABLE 94. INC: COMPANY SNAPSHOT
TABLE 95. INC: OPERATING SEGMENTS
TABLE 96. INC: PRODUCT PORTFOLIO
TABLE 97. INC: NET SALES,
TABLE 98. INC: KEY STRATERGIES
TABLE 99.BIOMERIEUX S.A: COMPANY SNAPSHOT
TABLE 100.BIOMERIEUX S.A: OPERATING SEGMENTS
TABLE 101.BIOMERIEUX S.A: PRODUCT PORTFOLIO
TABLE 102.BIOMERIEUX S.A: NET SALES,
TABLE 103.BIOMERIEUX S.A: KEY STRATERGIES
TABLE 104.BIO-RAD LABORATORIES: COMPANY SNAPSHOT
TABLE 105.BIO-RAD LABORATORIES: OPERATING SEGMENTS
TABLE 106.BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
TABLE 107.BIO-RAD LABORATORIES: NET SALES,
TABLE 108.BIO-RAD LABORATORIES: KEY STRATERGIES
TABLE 109. INC: COMPANY SNAPSHOT
TABLE 110. INC: OPERATING SEGMENTS
TABLE 111. INC: PRODUCT PORTFOLIO
TABLE 112. INC: NET SALES,
TABLE 113. INC: KEY STRATERGIES
TABLE 114.F. HOFFMANN-LA ROCHE AG (ROCHE): COMPANY SNAPSHOT
TABLE 115.F. HOFFMANN-LA ROCHE AG (ROCHE): OPERATING SEGMENTS
TABLE 116.F. HOFFMANN-LA ROCHE AG (ROCHE): PRODUCT PORTFOLIO
TABLE 117.F. HOFFMANN-LA ROCHE AG (ROCHE): NET SALES,
TABLE 118.F. HOFFMANN-LA ROCHE AG (ROCHE): KEY STRATERGIES
TABLE 119.FLUIDIGM CORPORATION: COMPANY SNAPSHOT
TABLE 120.FLUIDIGM CORPORATION: OPERATING SEGMENTS
TABLE 121.FLUIDIGM CORPORATION: PRODUCT PORTFOLIO
TABLE 122.FLUIDIGM CORPORATION: NET SALES,
TABLE 123.FLUIDIGM CORPORATION: KEY STRATERGIES
TABLE 124.LGC LIMITED: COMPANY SNAPSHOT
TABLE 125.LGC LIMITED: OPERATING SEGMENTS
TABLE 126.LGC LIMITED: PRODUCT PORTFOLIO
TABLE 127.LGC LIMITED: NET SALES,
TABLE 128.LGC LIMITED: KEY STRATERGIES
TABLE 129.QIAGEN N.V: COMPANY SNAPSHOT
TABLE 130.QIAGEN N.V: OPERATING SEGMENTS
TABLE 131.QIAGEN N.V: PRODUCT PORTFOLIO
TABLE 132.QIAGEN N.V: NET SALES,
TABLE 133.QIAGEN N.V: KEY STRATERGIES
TABLE 134.SYGNIS AG: COMPANY SNAPSHOT
TABLE 135.SYGNIS AG: OPERATING SEGMENTS
TABLE 136.SYGNIS AG: PRODUCT PORTFOLIO
TABLE 137.SYGNIS AG: NET SALES,
TABLE 138.SYGNIS AG: KEY STRATERGIES
TABLE 139.TAKARA BIO INC: COMPANY SNAPSHOT
TABLE 140.TAKARA BIO INC: OPERATING SEGMENTS
TABLE 141.TAKARA BIO INC: PRODUCT PORTFOLIO
TABLE 142.TAKARA BIO INC: NET SALES,
TABLE 143.TAKARA BIO INC: KEY STRATERGIES
TABLE 144.THERMO FISHER SCIENTIFIC INC: COMPANY SNAPSHOT
TABLE 145.THERMO FISHER SCIENTIFIC INC: OPERATING SEGMENTS
TABLE 146.THERMO FISHER SCIENTIFIC INC: PRODUCT PORTFOLIO
TABLE 147.THERMO FISHER SCIENTIFIC INC: NET SALES,
TABLE 148.THERMO FISHER SCIENTIFIC INC: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET SEGMENTATION
FIGURE 2.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030
FIGURE 3.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,BY TECHNOLOGY,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF REAL-TIME PCR POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF TRADITIONAL PCR POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DIGITAL PCR POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
FIGURE 15.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,BY PRODUCT,2020(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF REAGENTS & CONSUMABLES POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SOFTWARE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SERVICES POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
FIGURE 20.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,BY END USERS,2020(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC CENTERS & HOSPITALS POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF BIOTECH & PHARMA COMPANIES POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF ACADEMIC & RESEARCH INSTITUTIONS POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
FIGURE 24.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY REGION,2020
FIGURE 25.GERMANY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 26.UNITED KINGDOM POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 27.FRANCE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 28.ITALY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 29.REST OF EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 30.CHINA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 31.JAPAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 32.SOUTH KOREA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 33.INDIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 34.REST OF ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 35.U.S. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 36.CANADA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 37.MEXICO POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 38.LATIN AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 39.MIDDLE EAST POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 40.AFRICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 45.COMPETITIVE DASHBOARD
FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 47.AGILENT TECHNOLOGIES.: NET SALES ,($MILLION)
FIGURE 48. INC.: NET SALES ,($MILLION)
FIGURE 49.BIOMERIEUX S.A.: NET SALES ,($MILLION)
FIGURE 50.BIO-RAD LABORATORIES.: NET SALES ,($MILLION)
FIGURE 51. INC.: NET SALES ,($MILLION)
FIGURE 52.F. HOFFMANN-LA ROCHE AG (ROCHE).: NET SALES ,($MILLION)
FIGURE 53.FLUIDIGM CORPORATION.: NET SALES ,($MILLION)
FIGURE 54.LGC LIMITED.: NET SALES ,($MILLION)
FIGURE 55.QIAGEN N.V.: NET SALES ,($MILLION)
FIGURE 56.SYGNIS AG.: NET SALES ,($MILLION)
FIGURE 57.TAKARA BIO INC.: NET SALES ,($MILLION)
FIGURE 58.THERMO FISHER SCIENTIFIC INC.: NET SALES ,($MILLION)

ページTOPに戻る

Table of Contents

Summary

The global polymerase chain reaction technology market size was $16,669.3 million in 2020, and is expected to reach $28,755.1 million by 2030, with a CAGR of 4.1% from 2021 to 2030. Polymerase chain reaction (PCR) is a huge consistent methodology in the molecular biological science that upgrades single or barely any copies of a piece of DNA. Similarly, it is valuable in making thousands to millions of copies of a particular DNA gathering and investigating ailments such as AIDS, tuberculosis, Lyme disorder, and center ear infections. The development incorporates three huge advances; denaturation, hardening, and extension. It is applicable in clinical, research, clinical diagnostics, and legitimate sciences. It has been utilized since seemingly forever as a standard method for research on nucleic acids (RNA and DNA) in labs. PCR progresses available in the market are nonstop quantitative (qPCR), mechanized PCR (dPCR), computerized PCR, multiplex PCR, gathering PCR, and standard PCR. The need of strong illustrative diagnostic system in clinical consideration to perceive ailments empowers the premium for the advancement of the market.
Advancement in growth of infection and overwhelming contamination drive the polymerase chain reaction technologies market. For instance, cancer is one of the primary reasons of death across the globe. As per the National Cancer Institute, numerous people experience the ill effects of cancer. On account of the climb in the amount of patients encountering consistent contaminations, there is a development in the premium for PCR headways for the early investigation of sicknesses. From now on, various institutions have started with the therapy at the earliest, with the development in the inescapability of the infections. There is development in the interest in PCR advancements to perceive these afflictions toward the starting stages. Consequently, this positively impacts the development of the market. In addition, the progression in PCR propels by key part in industry help the advancement of the market by making advanced solutions open to the clinical services specialists for acknowledgment of various kinds of powerful disorders, threatening development, blood screening, and various applications, which drive the polymerase chain reaction technology market.
However, PCR tests can be used for the examination of various contaminations. Regardless, the cost related with the use of PCR progressions for the indicative tests are high. Consequently, patients do not select such tests. In like manner, various countries do not give reimbursement to these tests. The execution of these rates would achieve decline in reimbursement for key molecular tests, including inherited disease, molecular cytogenetics, and cancer testing. Consequently, nonappearance of reimbursements options further hinders the polymerase chain reaction technologies market growth for PCR developments.
On the contrary, the ascent in the occurrence of the infection and sicknesses such as cancer growth and contamination has expanded the interest of the characteristic techniques that could help in the early acknowledgment of these diseases. This has incited a development in sponsoring for the R&D activities that could help in the early finding of these diseases. In addition, critical associations put assets into the progress of the molecular diagnostics, for instance, PCR, expecting the development and demand in the field. The extension in sponsoring for R&D practices that incorporates the use of PCR for various purposes could extend the use of these advances and could offer new polymerase chain reaction technologies opportunity.
The Polymerase chain reaction technology market is segmented on the basis of technology, product, application, end user industry, and region. By technology, the market is divided into real-time PCR, traditional PCR, and digital PCR. By product, the market is fragmented into reagents & consumables, instruments, software, and services. By application, the market is classified into clinical, research, and forensics. By end user, the market is divided into diagnostic centers & hospitals, biotech & pharma companies, and academic & research institutions. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, South Korea, India, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).
The major players profiled in the polymerase chain reaction technology market include Abcam plc. (Expedeon AG), Agilent Technologies, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc. , F. Hoffmann-La Roche Ltd , Fluidigm , LGC Limited , Qiagen, Takara Bio Inc. , Thermo Fisher Scientific Inc.Major companies in the market have adopted product launch, partnership, and agreement as their key developmental strategies to offer better products and services to customers in the Polymerase chain reaction technology market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（consumables）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（consumables）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?